P02879 (RICI_RICCO) Ricinus communis (Castor bean)
Ricin UniProtKBInterProSTRINGInteractive Modelling
576 aa; Sequence (Fasta) ;
1 identical sequence: Ricinus communis: B9T8T0
It is possible new templates exist for this target since these models were created.
Available Structures
94 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystallographic refinement of ricin to 2.5 Angstroms |
Heteromer | 2×BGC; 2×NAG; | ||||
Assess | ||||||
Ricin bound to VHH antibody V6E11 |
Heteromer | 1×NAG; 2×NAG; 1×SO4; 3×EDO; 7×CL; | ||||
Assess | ||||||
Ricin bound to VHH antibody V5G1 |
Heteromer | 1×NAG; 1×NAG; 1×NAG; 4×ZN; 1×CL; | ||||
Assess | ||||||
Ricin bound to VHH antibody V5G6 |
Heteromer | 1×NAG; 1×NAG; 1×NAG; 4×ZN; 1×CL; | ||||
Assess | ||||||
Ricin bound to VHH antibody V11B2 |
Heteromer | 1×NAG; 1×NAG; 1×NAG; 5×ZN; 8×CL; | ||||
Assess | ||||||
Ricin bound to VHH antibody V2C11 |
Heteromer | 1×NAG; 2×NAG; 2×GAL; 2×EDO; 1×ZN; 6×CL; | ||||
Assess | ||||||
Crystal structure of ricin bound with dinucleotide ApG |
Heteromer | 2×BGC; 2×NAG; | ||||
Assess | ||||||
Ricin bound to VHH antibody V5E1 |
Heteromer | 2×NAG; 1×NAG; 4×CL; | ||||
Assess | ||||||
Ricin bound to VHH antibody V5E4 |
Heteromer | 1×NAG; 2×NAG; 1×EDO; 2×ZN; | ||||
Assess | ||||||
Ricin A chain bound to VHH antibody V6H8 |
Heteromer | 2×NI; 3×EDO; 1×IMD; | ||||
Assess | ||||||
V5E1-RTA complex |
Heteromer | 5×CL; 3×EDO; | ||||
Assess | ||||||
Ricin catalytic subunit bound go A9 VHH antibody |
Heteromer | |||||
Assess | ||||||
Ricin A chain bound to camelid nanobody (VHH4) |
Heteromer | |||||
Assess | ||||||
Ricin A chain bound to camelid nanobody (VHH1) |
Heteromer | 1×CL; 1×EDO; | ||||
Assess | ||||||
Ricin A chain bound to camelid nanobody (VHH8) |
Heteromer | |||||
Assess | ||||||
Single-domain VHH intrabodies neutralize ricin toxin. |
Heteromer | 2×EDO; 8×CL; | ||||
Assess | ||||||
Crystal structure of the RTA-c10-P2 complex |
Heteromer P05387; | |||||
Assess | ||||||
Ricin A chain bound to camelid |
Heteromer | 3×CL; 3×EDO; | ||||
Assess | ||||||
Ricin A chain bound to camelid nanobody (VHH5) |
Heteromer | 1×CL; | ||||
Assess | ||||||
Single-domain VHH intrabodies neutralize ricin toxin |
Heteromer | |||||
Assess | ||||||
Ricin A chain bound to VHH antibody V6A7 |
Heteromer | 1×CL; | ||||
Assess | ||||||
Crystal structure of ricin-A chain in complex with the antibody 6C2 |
Heteromer | |||||
Assess | ||||||
Ricin A chain bound to camelid nanobody (VHH9)(E1) |
Heteromer | 3×SO4; | ||||
Assess | ||||||
Ricin A chain bound to camelid nanobody (VHH2)(F5) |
Heteromer | 2×EDO; 1×ZN; 2×CL; | ||||
Assess | ||||||
Single-domain VHH intrabodies neutralize ricin toxin |
Heteromer | 11×CL; 1×MES; 1×SO4; | ||||
Assess | ||||||
Ricin toxin in complex with neutralizing single chain monoclonal antibodies (VHHs) |
Heteromer | 3×CL; | ||||
Assess | ||||||
Ricin A chain bound to VHH antibody V6A6 |
Heteromer | 3×ACY; 1×CA; 1×EDO; | ||||
Assess | ||||||
Ricin A chain bound to VHH antibody V8E6 |
Heteromer | 5×ZN; 2×CL; | ||||
Assess | ||||||
Ricin A chain bound to VHH antibody V6D4 |
Heteromer | 1×ZN; 1×CL; 1×IMD; 1×EDO; | ||||
Assess | ||||||
Ricin A chain bound to VHH antibody V2G10 |
Heteromer | 2×CL; 2×PG4; | ||||
Assess | ||||||
rRNA N-glycosylase RTA |
Heteromer P05387; | |||||
Assess | ||||||
Ricin A chain bound to camelid nanobody (VHH3) |
Heteromer | 3×ZN; 2×ACY; 8×CL; 2×EDO; | ||||
Assess | ||||||
RTA-V1C7 |
Heteromer | 1×PG4; 2×ACY; 1×EDO; 3×CL; | ||||
Assess | ||||||
RTA-V1C7-G29R-no_salt |
Heteromer | 1×CL; | ||||
Assess | ||||||
RTA-V1C7_G29R-high-salt |
Heteromer | 3×PO4; 5×CL; 1×EDO; | ||||
Assess | ||||||
Single-domain VHH intrabodies neutralize ricin toxin |
Heteromer | 5×CL; 1×EDO; | ||||
Assess | ||||||
RTA1-33/44-198 (RVEC) bound to Single Domain Antibody A3C8 |
Heteromer | 1×SO4; | ||||
Assess | ||||||
Crystal structure of ricin bound with formycin monophosphate | homo-2-mer | 2×BGC; 2×NAG; 1×FMP; | ||||
Assess | ||||||
Ricin A-Chain (Recombinant) E177D Mutant | homo-2-mer | 2×GOL; 4×SO4; | ||||
Assess | ||||||
RICIN A-CHAIN (RECOMBINANT) N122A MUTANT | homo-2-mer | 2×ACT; 4×SO4; | ||||
Assess | ||||||
Ricin A-Chain (Recombinant) E177D Mutant with a bound acetate | homo-2-mer | 2×ACT; 4×SO4; | ||||
Assess | ||||||
RICIN A-CHAIN (RECOMBINANT) R213D MUTANT | homo-2-mer | 4×SO4; | ||||
Assess | ||||||
RICIN A-CHAIN (RECOMBINANT) | homo-2-mer | |||||
Assess | ||||||
RICIN A-CHAIN (RECOMBINANT) COMPLEX WITH ADENOSINE (ADENOSINE BECOMES ADENINE IN THE COMPLEX) | homo-2-mer | 2×ADE; | ||||
Assess | ||||||
RICIN A-CHAIN (RECOMBINANT) COMPLEX WITH FORMYCIN | homo-2-mer | 2×FMC; | ||||
Assess | ||||||
STRUCTURE OF RICIN A CHAIN MUTANT, COMPLEX WITH AMP | homo-2-mer | 2×AMP; | ||||
Assess | ||||||
STRUCTURE OF RICIN A CHAIN MUTANT | homo-2-mer | |||||
Assess | ||||||
RICIN A CHAIN (RECOMBINANT) COMPLEX WITH PTEROIC ACID | monomer | 1×PT1; | ||||
Assess | ||||||
Crystal structure of ricin A chain in complex with inhibitor 9-oxo-4-fluorenecarboxamide | monomer | 1×R6T; 17×EDO; 10×CL; | ||||
Assess | ||||||
Structure of Ricin A chain bound with N-(N-(pterin-7-yl)carbonyl-L-serinyl)-L-tryptophan | monomer | 1×19L; 1×SO4; 2×MLA; | ||||
Assess | ||||||
Structure of ricin A chain bound with 2-amino-4-oxo-N-(2-(3-phenylureido)ethyl)-3,4-dihydropteridin… | monomer | 1×1MX; 1×SO4; 2×MLA; | ||||
Assess | ||||||
THE STRUCTURE OF RECOMBINANT RICIN A CHAIN AT 2.3 ANGSTROMS | monomer | |||||
Assess | ||||||
RICIN A CHAIN (RECOMBINANT) COMPLEX WITH NEOPTERIN | monomer | 1×NEO; | ||||
Assess | ||||||
STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 9-DEAZAGUANINE | monomer | 1×9DG; | ||||
Assess | ||||||
STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 2,5-DIAMINO-4,6-DIHYDROXYPYRIMIDINE (DDP) | monomer | 1×DDP; | ||||
Assess | ||||||
STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 7-DEAZAGUANINE | monomer | 1×7DG; | ||||
Assess | ||||||
STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 8-METHYL-9-OXOGUANINE | monomer | 1×MOG; | ||||
Assess | ||||||
Crystal structure of Ricin A chain bound with (S)-2-amino-N-(1-hydroxy-3-phenylpropan-2-yl)-4-oxo-3… | monomer | 2×IFX; 2×SO4; | ||||
Assess | ||||||
Crystal structure of Ricin A chain bound with (2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)-D-tyr… | monomer | 1×I9P; 2×SO4; | ||||
Assess | ||||||
Crystal structure of Ricin A chain bound with (S)-2-(2-amino-4-oxo-3,4-dihydropteridine-7-carboxami… | monomer | 2×IF4; 2×SO4; | ||||
Assess | ||||||
Crystal structure of Ricin A chain bound with N2-(2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)gly… | monomer | 1×IWQ; 2×SO4; | ||||
Assess | ||||||
Crystal structure of Ricin A chain bound with (2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)-D-phe… | monomer | 1×IEW; 2×SO4; | ||||
Assess | ||||||
Crystal structure of Ricin A chain bound with (2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)-L-tyr… | monomer | 2×I8T; 2×SO4; | ||||
Assess | ||||||
Structure of ricin A chain bound with benzyl-(2-(2-amino-4-oxo-3,4-dihydropteridine-7-carboxamido)e… | monomer | 1×5MX; | ||||
Assess | ||||||
Structure of Ricin A chain bound with N-(N-(pterin-7-yl)carbonylglycyl)-L-phenylalanine | monomer | 1×RS8; | ||||
Assess | ||||||
Crystal structure of Ricin A chain bound with (S)-2-(2-amino-4-oxo-3,4-dihydropteridine-7-carboxami… | monomer | 2×IEZ; 2×SO4; | ||||
Assess | ||||||
Structure of ricin A chain bound with N-(N-(pterin-7-yl)carbonylglycyl)-L-phenylalanyl)-L-phenylala… | monomer | 1×19M; 2×SO4; 2×MLA; | ||||
Assess | ||||||
Structure of ricin A chain bound with N-(N-(pterin-7-yl)carbonylglycyl)glycine | monomer | 1×19J; 1×SO4; 1×MLA; | ||||
Assess | ||||||
Crystal structure of Ricin A chain bound with (2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)glycyl… | monomer | 1×RS8; 2×SO4; | ||||
Assess | ||||||
Ricin A-Chain (Recombinant) at 100K | monomer | 2×GLC; 2×SO4; | ||||
Assess | ||||||
Structure of Rivax: A Human Ricin Vaccine | monomer | 2×SO4; | ||||
Assess | ||||||
Crystal structure of Ricin A chain bound with N2-(2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)gly… | monomer | 1×JKU; 2×SO4; | ||||
Assess | ||||||
Structure of ricin A chain bound with N-((1H-1,2,3-triazol-4-yl)methyl-2-amino-4-oxo-3,4-dihydropte… | monomer | 1×0RB; | ||||
Assess | ||||||
Crystal structure of Ricin A chain bound with (R)-2-(2-amino-4-oxo-3,4-dihydropteridine-7-carboxami… | monomer | 1×IFH; 2×SO4; | ||||
Assess | ||||||
Crystal structure of ricin A chain in complex with 5-mesitylthiophene-2-carboxylic acid | monomer | 1×ZJ7; 2×EDO; 1×SO4; | ||||
Assess | ||||||
Crystal structure of ricin A chain in complex with inhibitor 4-(2-thienylmethyl)benzoic acid | monomer | 22×EDO; 1×DMS; 1×R7T; | ||||
Assess | ||||||
Crystal structure of Ricin A chain bound with (S)-2-(2-amino-4-oxo-3,4-dihydropteridine-7-carboxami… | monomer | 2×IFQ; 2×SO4; | ||||
Assess | ||||||
Crystal structure of Ricin A chain bound with (2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)-L-phe… | monomer | 2×IEK; 2×SO4; | ||||
Assess | ||||||
Crystal structure of ricin A chain in complex with inhibitor 5-phenyl-2-thiophenecarboxylic acid | monomer | 15×EDO; 1×JMG; 1×DMS; | ||||
Assess | ||||||
Crystal structure of Ricin A-chain in complex with the cyclic tetranucleotide inhibitor, a transiti… | monomer | 1×C2X; 1×SO4; | ||||
Assess | ||||||
Crystal Structure of Ricin A chain complexed with Baicalin inhibitor | monomer | 1×0XE; | ||||
Assess | ||||||
RTA in complex with 7-carboxy-pterin | monomer | 1×JP2; | ||||
Assess | ||||||
Crystal structure of ricin A chain in complex with 5-(o-tolyl)thiophene-2-carboxylic acid | monomer | 1×ZJA; 3×GOL; | ||||
Assess | ||||||
Ricin a-chain (recombinant) complex with n-methylurea | monomer | 2×SO4; 1×NMU; | ||||
Assess | ||||||
RTA in complex with N-(furanylmethyl)-7-carbamoyl-pterin | monomer | 1×JP3; | ||||
Assess | ||||||
Ricin a-chain (recombinant) complex with adenine | monomer | 3×SO4; 1×ADE; | ||||
Assess | ||||||
Ricin A-chain (recombinant) complex with Acetamide | monomer | 2×SO4; 1×ACM; | ||||
Assess | ||||||
Ricin A-chain (recombinant) complex with Urea | monomer | 2×SO4; 1×URE; | ||||
Assess | ||||||
Crystal structure of ricin A chain in complex with 5-(2,6-dimethylphenyl)thiophene-2-carboxylic acid | monomer | 1×ZJ4; 6×EDO; 2×ZN; | ||||
Assess | ||||||
complex of Ricin A chain and pyrimidine-based inhibitor | monomer | 1×EJ5; | ||||
Assess | ||||||
Crystal structure of ricin A chain in complex with 5-(2-ethylphenyl)thiophene-2-carboxylic acid | monomer | 3×CL; 18×EDO; 1×ZJD; | ||||
Assess | ||||||
Stabilized Ricin Immunogen 1-33/44-198 | monomer | 1×SO4; | ||||
Assess | ||||||
Ricin A-chain variant 1-33/44-198 with engineered disulfide bond, R48C/T77C/D75N | monomer | 1×SO4; | ||||
Assess | ||||||
Ricin A-chain variant 1-33/44-198 with engineered disulfide bond | monomer | 1×SO4; | ||||
Assess |
3 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
5ddz.1.A | monomer | 0.85 | 100.00 | |||
Assess | ||||||
7kc9.1.B | monomer | 0.83 | 100.00 | |||
Assess | ||||||
6nqt.1.A | monomer | 0.61 | 20.69 | |||
Assess |